Background: Antivirals for the treatment of hepatitis C virus (HCV) infection are effective, but
many patients remain untreated and treatment is not yet routine in primary care. We …

Background: Despite antiviral agents that can cure the disease, many individuals with
Hepatitis C Virus (HCV) remain untreated. Primary care clinicians can play an important role …

• Limited access to specialists and lack of provider expertise in hepatitis C (HCV) treatment
remain significant barriers in the hepatitis C care cascade• Given the advent of directly …

BACKGROUND: The introduction of the first direct-acting antiviral agents (DAAs) for the
treatment of hepatitis C virus (HCV), telaprevir and boceprevir, marked a unique event in …

Objective. New, highly effective hepatitis C virus (HCV) medications recently changed the
landscape of HCV treatment. Access to treatment, however, is limited. The New York City …

Abstract BACKGROUND: Hepatitis C virus (HCV) infection is both prevalent and
undertreated. OBJECTIVE: To identify barriers to HCV treatment in primary care practice …

The role of primary care physicians in providing care for hepatitis C virus (HCV) infection is
increasingly emphasized, but many gaps and challenges remain. This study explores family …

Background: Hepatitis C virus (HCV) infection remains underdiagnosed and undertreated,
but treatment advances may allow primary care providers to address gaps in care by …

Background Curative treatment for hepatitis C virus (HCV) exists, making elimination of HCV
possible. However, most people with HCV have not received treatment. One barrier is …

Quality gaps exist in the hepatitis C virus (HCV) care process from diagnosis to cure. To
better understand current gaps and to identify targets for quality improvement, we …